Yong Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yong Liu has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Supeng Ding
Jiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry & Molecular Biology, Xuzhou Medical University, Xuzhou, People’s Republic of China
2 shared publicationsYifei Luan
Jiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry & Molecular Biology, Xuzhou Medical University, Xuzhou, People’s Republic of China
2 shared publicationsZhichao Zhu
Jiangsu Key Laboratory of Brain Disease Bioinformation, Research Center for Biochemistry & Molecular Biology, Xuzhou Medical University, Xuzhou, People’s Republic of China
2 shared publications- Bei Liu
Department of Biochemistry, Duke University School of Medicine, Durham, NC, USA
1 shared publication - Can Wu
National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, Sichuan, 610065, China
1 shared publication - Chong Li
School of Biological Sciences, Xuzhou Medical University, Xuzhou, P.R. China
1 shared publication
Latest Publications
- 14 March 2025
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (3) , 1-12
Quercetin inhibited chronic unpredictable mild stress-induced mouse depressive behaviors through attenuating lateral Habenula neuronal activities
As a flavonoid, quercetin has shown anti-tumor, anti-inflammation, and anti-depressant effects. However, the exact anti-depressant mechanism of quercetin remains unclear. In this study, a combination of behavioral tests and neuropharmacological methods were used to investigate whether the endocannabinoid (eCB) system in the lateral habenula (LHb) mediated the anti-depressant pathogenesis of quercetin. Depressive model was prepared by chronic unpredictable mild stress (CUMS) in C57 mice. The CUMS exposure led to depressive-like behaviors and an increase of the miniature excitatory postsynaptic current (mEPSC) frequency in the LHb neurons, which were blocked by quercetin intragastrically administered for 14 days. As quercetin has been shown to upregulate the mRNA expression of cannabinoid receptor 1 (CB1) in cultured tumor cells, and the inhibitory effect of eCB system activation is related to glutamatergic neurons, depolarization-induced suppression of excitation (sDSE) was detected. The results showed that presynaptic inhibitory effect of eCB system was significantly down-regulated in the LHb of CUMS model, and the down-regulation was abolished by quercetin. Blocking eCB system in the LHb with CB1 antagonist AM251 rescued the neuroprotective effects of quercetin in CUMS mice. Taken together, the results suggested that eCB system in the LHb was involved in the anti-depressant effects of quercetin. Graphical Abstract
- 14 March 2025
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 40 (3) , 1-12
Quercetin inhibited chronic unpredictable mild stress-induced mouse depressive behaviors through attenuating lateral Habenula neuronal activities
As a flavonoid, quercetin has shown anti-tumor, anti-inflammation, and anti-depressant effects. However, the exact anti-depressant mechanism of quercetin remains unclear. In this study, a combination of behavioral tests and neuropharmacological methods were used to investigate whether the endocannabinoid (eCB) system in the lateral habenula (LHb) mediated the anti-depressant pathogenesis of quercetin. Depressive model was prepared by chronic unpredictable mild stress (CUMS) in C57 mice. The CUMS exposure led to depressive-like behaviors and an increase of the miniature excitatory postsynaptic current (mEPSC) frequency in the LHb neurons, which were blocked by quercetin intragastrically administered for 14 days. As quercetin has been shown to upregulate the mRNA expression of cannabinoid receptor 1 (CB1) in cultured tumor cells, and the inhibitory effect of eCB system activation is related to glutamatergic neurons, depolarization-induced suppression of excitation (sDSE) was detected. The results showed that presynaptic inhibitory effect of eCB system was significantly down-regulated in the LHb of CUMS model, and the down-regulation was abolished by quercetin. Blocking eCB system in the LHb with CB1 antagonist AM251 rescued the neuroprotective effects of quercetin in CUMS mice. Taken together, the results suggested that eCB system in the LHb was involved in the anti-depressant effects of quercetin. Graphical Abstract
- Open Access
- 21 November 2023
- Published by Elsevier in Neuroscience
- Vol. 536, 131-142
Phosphorylation of 4.1N by CaMKII Regulates the Trafficking of GluA1-containing AMPA Receptors During Long-term Potentiation in Acute Rat Hippocampal Brain Slices
- 21 November 2023
- Published by Elsevier in Neuroscience
- Vol. 536, 131-142
Open AccessPhosphorylation of 4.1N by CaMKII Regulates the Trafficking of GluA1-containing AMPA Receptors During Long-term Potentiation in Acute Rat Hippocampal Brain Slices
- 21 December 2022
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 222, 173510
ERK signaling is required for nicotine-induced conditional place preference by regulating neuroplasticity genes expression in male mice
- 21 December 2022
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 222, 173510
ERK signaling is required for nicotine-induced conditional place preference by regulating neuroplasticity genes expression in male mice
- Open Access
- 1 January 2022
- Published by TMR Publishing Group in TMR Pharmacology Research
- Vol. 2 (2) , 9
Exploring the mechanism of action of San Huang lotion for the topical treatment of eczema based on network pharmacology and molecular docking techniques
- 1 January 2022
- Published by TMR Publishing Group in TMR Pharmacology Research
- Vol. 2 (2) , 9
Open AccessExploring the mechanism of action of San Huang lotion for the topical treatment of eczema based on network pharmacology and molecular docking techniques
- 31 August 2021
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 36 (8) , 2299-2311
Ginkgo biloba extracts inhibit post-ischemic LTP through attenuating EPSCs in rat hippocampus
Ginkgo biloba extract 761 (EGb761), a standardized extract from the Ginkgo biloba leaf, is purported to inhibit NMDA receptor-mediated neuronal excitotoxicity and protect neurons form ischemic injury. However, the specific signal pathway involved in the effects of EGb761 on synaptic plasticity is still in dispute. In this article, effects of EGb761 and its monomer component ginkgolide A (GA), ginkgolide B (GB), ginkgolide C (GC) and quercetin on rat hippocampal synaptic plasticity were studied. The evoked Excitatory postsynaptic currents (EPSCs) and miniature EPSCs were recorded on hippocampal slices from SD rats (14–21 days of age) by whole-cell patch-clamp recording and long-term potentiation (LTP) was induced by theta-burst stimulation. Acutely applied EGb761 inhibited the LTP, but bilaterally affect the evoked EPSCs. The evoked EPSCs were increased by incubation of lower concentration of EGb761, then the evoked EPSCs were decreased by incubation of higher concentration of EGb761. EGb761 monomer component GA, GB and GC could also inhibit the TBS-induced LTP and EPSC amplitude but not paired-pulse ratio (PPR). But quercetin, another monomer component of EGb761, led to increase in EPSC amplitude and decrease in PPR. Simultaneously, EGb761 and its monomer component ginkgolides inhibited the post-ischemic LTP (i-LTP) by inhibiting the EPSCs and the AMPA receptor subunit GluA1 expression on postsynaptic membrane. The results indicated that high concentration of EGb761 might inhibit LTP and i-LTP through inhibition effects of GA, GB and GC on AMPA receptors.
- 31 August 2021
- Published by Springer Nature in Metabolic Brain Disease
- Vol. 36 (8) , 2299-2311
Ginkgo biloba extracts inhibit post-ischemic LTP through attenuating EPSCs in rat hippocampus
Ginkgo biloba extract 761 (EGb761), a standardized extract from the Ginkgo biloba leaf, is purported to inhibit NMDA receptor-mediated neuronal excitotoxicity and protect neurons form ischemic injury. However, the specific signal pathway involved in the effects of EGb761 on synaptic plasticity is still in dispute. In this article, effects of EGb761 and its monomer component ginkgolide A (GA), ginkgolide B (GB), ginkgolide C (GC) and quercetin on rat hippocampal synaptic plasticity were studied. The evoked Excitatory postsynaptic currents (EPSCs) and miniature EPSCs were recorded on hippocampal slices from SD rats (14–21 days of age) by whole-cell patch-clamp recording and long-term potentiation (LTP) was induced by theta-burst stimulation. Acutely applied EGb761 inhibited the LTP, but bilaterally affect the evoked EPSCs. The evoked EPSCs were increased by incubation of lower concentration of EGb761, then the evoked EPSCs were decreased by incubation of higher concentration of EGb761. EGb761 monomer component GA, GB and GC could also inhibit the TBS-induced LTP and EPSC amplitude but not paired-pulse ratio (PPR). But quercetin, another monomer component of EGb761, led to increase in EPSC amplitude and decrease in PPR. Simultaneously, EGb761 and its monomer component ginkgolides inhibited the post-ischemic LTP (i-LTP) by inhibiting the EPSCs and the AMPA receptor subunit GluA1 expression on postsynaptic membrane. The results indicated that high concentration of EGb761 might inhibit LTP and i-LTP through inhibition effects of GA, GB and GC on AMPA receptors.
- Open Access
- 7 July 2021
- Published by Springer Nature in Research Square
Ginkgo Biloba Extracts Inhibit Ischemic LTP Through Attenuating EPSCs In Rat Hippocampus
Ginkgo biloba extract 761 (Egb761), a standardized extract from the Ginkgo biloba leaf, is purported to inhibit NMDA receptor-mediated neuronal excitotoxicity and protect neurons form ischemic injury. However, the specific signal pathway involved in the effects of Egb761 on synaptic plasticity is still in dispute. In this article, effects of Egb761 and its monomer component Ginkgolide A (GA), Ginkgolide B (GB) and Ginkgolide C (GC) on rat hippocampal synaptic plasticity were studied. The evoked Excitatory postsynaptic currents (EPSCs) and miniature EPSCs were recorded on hippocampal slices from SD rats (14–21 days of age) by whole-cell patch-clamp recording and long-term potentiation (LTP) was induced by theta-burst stimulation. Acutely applied Egb761 inhibited the LTP, but bilaterally affect the EPSCs, that is EPSC increase at lower concentration of Egb761, then EPSC decrease at higher concentration of Egb761. Egb761 monomer component GA, GB and GC could also inhibit the TBS-induced LTP and EPSC amplitude but not paired-pulse ratio (PPR). Simultaneously, Egb761 and its monomer components inhibited the post-ischemic LTP (i-LTP) by inhibiting the EPSCs and the AMPA receptor subunit GluA1 expression on postsynaptic membrane. The results indicated that high concentration of Egb761 might inhibit LTP and i-LTP through inhibition effects of GA, GB and GC on AMPA receptors.
- 7 July 2021
- Published by Springer Nature in Research Square
Open AccessGinkgo Biloba Extracts Inhibit Ischemic LTP Through Attenuating EPSCs In Rat Hippocampus
Ginkgo biloba extract 761 (Egb761), a standardized extract from the Ginkgo biloba leaf, is purported to inhibit NMDA receptor-mediated neuronal excitotoxicity and protect neurons form ischemic injury. However, the specific signal pathway involved in the effects of Egb761 on synaptic plasticity is still in dispute. In this article, effects of Egb761 and its monomer component Ginkgolide A (GA), Ginkgolide B (GB) and Ginkgolide C (GC) on rat hippocampal synaptic plasticity were studied. The evoked Excitatory postsynaptic currents (EPSCs) and miniature EPSCs were recorded on hippocampal slices from SD rats (14–21 days of age) by whole-cell patch-clamp recording and long-term potentiation (LTP) was induced by theta-burst stimulation. Acutely applied Egb761 inhibited the LTP, but bilaterally affect the EPSCs, that is EPSC increase at lower concentration of Egb761, then EPSC decrease at higher concentration of Egb761. Egb761 monomer component GA, GB and GC could also inhibit the TBS-induced LTP and EPSC amplitude but not paired-pulse ratio (PPR). Simultaneously, Egb761 and its monomer components inhibited the post-ischemic LTP (i-LTP) by inhibiting the EPSCs and the AMPA receptor subunit GluA1 expression on postsynaptic membrane. The results indicated that high concentration of Egb761 might inhibit LTP and i-LTP through inhibition effects of GA, GB and GC on AMPA receptors.
- 1 February 2021
- Published by Elsevier in Brain Research Bulletin
- Vol. 167, 1-10
Upregulated Nmnat2 causes neuronal death and increases seizure susceptibility in temporal lobe epilepsy
- 1 February 2021
- Published by Elsevier in Brain Research Bulletin
- Vol. 167, 1-10
Upregulated Nmnat2 causes neuronal death and increases seizure susceptibility in temporal lobe epilepsy
- 1 June 2010
- Published by Elsevier in Neuroscience
- Vol. 167 (4) , 1125-1137
Neuroprotection of ethanol against ischemia/reperfusion-induced brain injury through decreasing c-Jun N-terminal kinase 3 (JNK3) activation by enhancing GABA release
- 1 June 2010
- Published by Elsevier in Neuroscience
- Vol. 167 (4) , 1125-1137
Neuroprotection of ethanol against ischemia/reperfusion-induced brain injury through decreasing c-Jun N-terminal kinase 3 (JNK3) activation by enhancing GABA release